Singer CF, Pfeiler G, Hubalek M, Bartsch R, et al. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). Eur J Cancer 2020;132:43-52.
PMID: 32325419